Kewaunee Scientific Corporation (NASDAQ:KEQU - Get Free Report) CEO Thomas David Hull III sold 1,000 shares of Kewaunee Scientific stock in a transaction dated Wednesday, October 1st. The shares were sold at an average price of $43.09, for a total value of $43,090.00. Following the sale, the chief executive officer owned 38,719 shares of the company's stock, valued at approximately $1,668,401.71. This trade represents a 2.52% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available at the SEC website.
Thomas David Hull III also recently made the following trade(s):
- On Monday, September 29th, Thomas David Hull III sold 1,854 shares of Kewaunee Scientific stock. The stock was sold at an average price of $43.42, for a total value of $80,500.68.
- On Wednesday, September 24th, Thomas David Hull III sold 1,000 shares of Kewaunee Scientific stock. The stock was sold at an average price of $43.62, for a total value of $43,620.00.
- On Tuesday, September 23rd, Thomas David Hull III sold 721 shares of Kewaunee Scientific stock. The shares were sold at an average price of $44.00, for a total value of $31,724.00.
- On Friday, September 19th, Thomas David Hull III sold 773 shares of Kewaunee Scientific stock. The stock was sold at an average price of $45.34, for a total value of $35,047.82.
- On Thursday, September 18th, Thomas David Hull III sold 652 shares of Kewaunee Scientific stock. The shares were sold at an average price of $46.00, for a total value of $29,992.00.
Kewaunee Scientific Trading Down 0.8%
Shares of KEQU stock traded down $0.35 on Thursday, reaching $43.85. 8,448 shares of the company's stock were exchanged, compared to its average volume of 17,388. The company has a current ratio of 2.32, a quick ratio of 1.63 and a debt-to-equity ratio of 0.88. The company's fifty day simple moving average is $52.24 and its 200 day simple moving average is $45.34. The stock has a market capitalization of $125.85 million, a PE ratio of 10.62 and a beta of 0.68. Kewaunee Scientific Corporation has a 52 week low of $30.33 and a 52 week high of $71.33.
Kewaunee Scientific (NASDAQ:KEQU - Get Free Report) last announced its earnings results on Wednesday, September 10th. The technology company reported $1.10 earnings per share (EPS) for the quarter. Kewaunee Scientific had a return on equity of 25.65% and a net margin of 4.68%.The company had revenue of $71.10 million for the quarter.
Institutional Trading of Kewaunee Scientific
Several large investors have recently modified their holdings of KEQU. Bank of America Corp DE lifted its holdings in Kewaunee Scientific by 2,605.9% in the fourth quarter. Bank of America Corp DE now owns 460 shares of the technology company's stock worth $28,000 after acquiring an additional 443 shares during the last quarter. IFP Advisors Inc boosted its stake in shares of Kewaunee Scientific by 61.5% during the 1st quarter. IFP Advisors Inc now owns 945 shares of the technology company's stock valued at $37,000 after buying an additional 360 shares during the period. Raymond James Financial Inc. acquired a new stake in shares of Kewaunee Scientific in the 2nd quarter valued at $60,000. Wedbush Securities Inc. bought a new position in Kewaunee Scientific in the 2nd quarter worth $232,000. Finally, Morgan Dempsey Capital Management LLC increased its holdings in shares of Kewaunee Scientific by 41.8% during the 2nd quarter. Morgan Dempsey Capital Management LLC now owns 4,229 shares of the technology company's stock worth $247,000 after purchasing an additional 1,247 shares during the period. 32.69% of the stock is currently owned by institutional investors and hedge funds.
Analysts Set New Price Targets
Separately, Wall Street Zen upgraded Kewaunee Scientific from a "hold" rating to a "buy" rating in a report on Saturday, July 5th.
Read Our Latest Analysis on Kewaunee Scientific
Kewaunee Scientific Company Profile
(
Get Free Report)
Kewaunee Scientific Corporation designs, manufactures, and installs laboratory, healthcare, and technical furniture and infrastructure products. The company operates through two segments, Domestic and International. Its products include steel and wood casework, fume hoods, adaptable modular systems, moveable workstations, stand-alone benches, biological safety cabinets, and epoxy resin work surfaces and sinks.
Featured Articles

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Kewaunee Scientific, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Kewaunee Scientific wasn't on the list.
While Kewaunee Scientific currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.